tiprankstipranks
Omega Therapeutics (OMGA)
NASDAQ:OMGA
US Market

Omega Therapeutics (OMGA) Financial Statements

331 Followers

Omega Therapeutics Financial Overview

Omega Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.674; its P/E ratio is -1.22; Omega Therapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 989.00K$ 831.00K$ 759.00K$ 516.00K$ 734.00K
Gross Profit$ 1.17M$ 1.44M$ 378.00K$ 104.00K$ -205.00K
EBIT$ -20.70M$ -22.46M$ -30.20M$ -26.38M$ -32.06M
EBITDA$ -18.92M-$ 0.00$ -25.02M$ -27.84M
Net Income Common Stockholders$ -20.21M$ -22.25M$ -29.69M$ -25.28M$ -30.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 73.43M$ 89.30M$ 112.98M$ 136.79M$ 124.68M
Total Assets$ 204.37M$ 217.81M$ 229.05M$ 156.31M$ 141.84M
Total Debt$ 128.40M$ 131.20M$ 118.63M$ 22.23M$ 22.53M
Net Debt$ 54.97M$ 41.90M$ 5.65M$ -114.55M$ -102.14M
Total Liabilities$ 146.35M$ 141.76M$ 133.11M$ 33.31M$ 145.95M
Stockholders Equity$ 58.02M$ 76.04M$ 95.92M$ 123.00M$ 105.97M
Cash Flow-
Free Cash Flow---$ -28.08M$ -24.51M
Operating Cash Flow$ -17.11M$ -23.00M-$ -28.08M$ -24.22M
Investing Cash Flow$ 2.14M$ -724.00K-$ 22.05M$ 17.65M
Financing Cash Flow$ 1.63M$ -8.00K-$ 39.99M$ 586.00K
Currency in USD

Omega Therapeutics Earnings and Revenue History

Omega Therapeutics Debt to Assets

Omega Therapeutics Cash Flow

Omega Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis